ZAFGEN, INC. Business Finance Contracts & Agreements

29 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Non-Qualified Stock Option Grant Notice and Award Agreement
Stock Agreements
ZAFGEN, INC.
Biotechnology
DE
2024
Underwriting Agreement, dated February 14, 2024, by and among the Company, Leerink Partners LLC, Citigroup Global Markets Inc. and Guggenheim Securities, LLC, as representatives...
Underwriting Agreements
ZAFGEN, INC.
Biotechnology
NY
2024
Underwriting Agreement
Underwriting Agreements
ZAFGEN, INC.
Biotechnology
NY
2022
Form of Amended and Restated Registration Rights Agreement, by and among Larimar Therapeutics, Inc. and certain Investors
Registration Rights Agreements
ZAFGEN, INC.
Biotechnology
DE
2021
Form of Registration Rights Agreement, by and among Larimar Therapeutics, Inc. and certain Investors
Registration Rights Agreements
ZAFGEN, INC.
Biotechnology
DE
2021
Securities Purchase Agreement, dated as of May 21, 2021, by and among Larimar Therapeutics, Inc. and the investors listed on the Schedule of Investors attached thereto
Investor Rights Agreements
ZAFGEN, INC.
Biotechnology
DE
2021
Form of Pre-Funded Warrant
Warrant Agreements
ZAFGEN, INC.
Biotechnology
DE
2021
Larimar Therapeutics, Inc. Form of Stock Option Grant Notice and Award Agreement
Stock Agreements
ZAFGEN, INC.
Biotechnology
DE
2020
Larimar Therapeutics, Inc. Form of Stock Option Grant Notice and Award Agreement
Stock Agreements
ZAFGEN, INC.
Biotechnology
DE
2020
Registration Rights Agreement, dated as of June 1, 2020 by and among Larimar Therapeutics, Inc. and certain Investors
Registration Rights Agreements
ZAFGEN, INC.
Biotechnology
DE
2020
Securities Purchase Agreement, dated as of May 28, 2020 by and among Larimar Therapeutics, Inc. and the investors listed on the Schedule of Investors attached thereto
Investor Rights Agreements
ZAFGEN, INC.
Biotechnology
DE
2020
Form of Pre-Funded Warrant
Warrant Agreements
ZAFGEN, INC.
Biotechnology
DE
2020
First Amendment to Non-Qualified Stock Option Agreement Inducement Award by and between Registrant and Jeffrey S. Hatfield granted on October 9, 2017
Stock Agreements
ZAFGEN, INC.
Biotechnology
DE
2020
Description of Registrants Securities 10.1# Amended and Restated 2006 Stock Option Plan and forms of award agreements thereunder (incorporated by reference to Exhibit 10.1 of the...
Stock Agreements
ZAFGEN, INC.
Biotechnology
2020
Non-Qualified Stock Option Agreement Inducement Award by and between the Registrant and Priya Singhal, M.D., M.P.H. granted on April 2, 2019
Stock Agreements
ZAFGEN, INC.
Biotechnology
2019
Non-Qualified Stock Option Agreement Inducement Award by and between Registrant and Brian P. McVeigh granted on May 29, 2018
Stock Agreements
ZAFGEN, INC.
Biotechnology
2018
Underwriting Agreement, dated as of June 27, 2018, among Zafgen, Inc. and Cowen and Company, LLC and Piper Jaffray & Co., as representatives of the underwriters named therein
Underwriting Agreements
ZAFGEN, INC.
Biotechnology
NY
2018
Waiver to Financing Condition by and between Registrant and Jeffrey S. Hatfield, effective as of December 29, 2017
Waiver Agreements
ZAFGEN, INC.
Biotechnology
2018
Non-Qualified Stock Option Agreement Inducement Award by and between Registrant and Jeffrey S. Hatfield granted on October 9, 2017
Stock Agreements
ZAFGEN, INC.
Biotechnology
2018
Non-Qualified Stock Option Agreement Inducement Award by and between Registrant and Jeffrey S. Hatfield granted on October 9, 2017
Stock Agreements
ZAFGEN, INC.
Biotechnology
2018
Loan and Security Agreement dated December 29, 2017 between Zafgen, Inc., as borrower, and Silicon Valley Bank, as lender
Loan Agreements
ZAFGEN, INC.
Biotechnology
CA
2018
ZAFGEN, INC. [] Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreements
ZAFGEN, INC.
Biotechnology
NY
2015
SUBSCRIPTION AGREEMENT
Subscription Agreements
ZAFGEN, INC.
Biotechnology
MA
2015
ZAFGEN, INC. 2014EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
ZAFGEN, INC.
Biotechnology
DE
2014
ZAFGEN, INC. [] Shares ofCommon Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreements
ZAFGEN, INC.
Biotechnology
NY
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 EXCLUSIVE...
Exchange Agreements
ZAFGEN, INC.
Biotechnology
2014
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 EXCLUSIVE...
Exchange Agreements
ZAFGEN, INC.
Biotechnology
2014
ZAFGEN, INC. AMENDED AND RESTATED 2006 STOCK OPTIONPLAN
Stock Agreements
ZAFGEN, INC.
Biotechnology
MA
2014
THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT BY AND AMONG ZAFGEN,INC. AND THEINVESTORS NAMED HEREIN November 25, 2013 TABLE OF CONTENTS
Investor Rights Agreements
ZAFGEN, INC.
Biotechnology
DE
2014